Back to National Bank of Canada National Bank of Canada

MRNAMRNA

Showing 8 of 19 quarters

Position history for National Bank of CanadaNational Bank of Canada's holdings in Moderna, Inc.

Yes. National Bank of Canada holds 1,424,802 shares of MRNA (Moderna), worth $99.8M, as of its Q2 2026 13F filing. It reduced the position by 392,199 shares (-21.6%) from Q1 2026. National Bank of Canada has held MRNA in every 13F on record since Q4 2021, 19 quarterly filings. MRNA is 0.1% of National Bank of Canada's reported 13F portfolio.

Current Value

$99.8M

Current Shares

1.4M

Total Value Change

+$84.1M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.4M
-21.6%
$99.8M0.1%$70.03
0
2026-Q1
Decreased
1.8M
-15.7%
$92.3M0.1%$50.80
0
2025-Q4
Decreased
2.2M
-20.3%
$63.6M0.1%$29.49
0
2025-Q3
Increased
2.7M
+356.8%
$69.9M0.1%$25.83
48
2025-Q2
Decreased
592,194
-42.2%
$16.3M0.0%$27.59
0
2025-Q1
Increased
1M
+506.3%
$29.1M0.0%$28.35
46
2024-Q4
Decreased
169,075
-28.1%
$7M0.0%$41.58
0
2024-Q3
Increased
235,266
+62.8%
$15.7M0.0%$65.75
41

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used